Zimmer climbs after raising annual profit forecast
ZBH•Zimmer Biomet shares rise after guidance increase
Shares of medical device maker Zimmer Biomet Holdings (ZBH.N) rise 2.9% to $98.56 premarket.
- The company expects annual profit per share between $8.47 and $8.59, above its previous expectation of $8.40 to $8.55.
- Zimmer Biomet reports Q2 adjusted profit of $2.07/share versus analysts' average estimate of $2.01/share, according to LSEG data.
- Q2 revenue of $2.18 billion beats analysts' average expectation of $2.13 billion on strength in its hips business.
- Up to the last close, the stock was up 6.6% year to date.
